CEFTIN SUMMARY
CEFTIN Tablets and CEFTIN for Oral Suspension contain cefuroxime as cefuroxime axetil. CEFTIN is a semisynthetic, broad-spectrum cephalosporin antibiotic for oral administration.
NOTE: CEFTIN TABLETS AND CEFTIN FOR ORAL SUSPENSION ARE NOT BIOEQUIVALENT AND ARE NOT SUBSTITUTABLE ON A MILLIGRAM-PER-MILLIGRAM BASIS (SEE CLINICAL PHARMACOLOGY).
CEFTIN Tablets
CEFTIN Tablets are indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below:
-
1.
Pharyngitis
/Tonsillitis caused by Streptococcus
pyogenes
.
-
NOTE: The usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. CEFTIN Tablets are generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefuroxime in the subsequent prevention of rheumatic fever are not available. Please also note that in all clinical trials, all isolates had to be sensitive to both penicillin and cefuroxime. There are no data from adequate and well-controlled trials to demonstrate the effectiveness of cefuroxime in the treatment of penicillin-resistant strains of Streptococcus
pyogenes
.
-
2.
Acute Bacterial
Otitis
Media caused by Streptococcus
pneumoniae, Haemophilus
influenzae
(including beta-lactamase?producing strains), Moraxella
catarrhalis (including beta-lactamase?producing strains), or Streptococcus
pyogenes
.
-
3.
Acute Bacterial Maxillary Sinusitis caused by Streptococcus
pneumoniae
or
Haemophilus
influenzae (non-beta-lactamase?producing strains only) (see CLINICAL STUDIES).
-
NOTE: In view of the insufficient numbers of isolates of beta-lactamase?producing strains of Haemophilus
influenzae and Moraxella
catarrhalis that were obtained from clinical trials with CEFTIN Tablets for patients with acute bacterial maxillary sinusitis, it was not possible to adequately evaluate the effectiveness of CEFTIN Tablets for sinus infections known, suspected, or considered potentially to be caused by beta-lactamase?producing Haemophilus
influenzae or Moraxella
catarrhalis.
-
4.
Acute Bacterial Exacerbations of Chronic Bronchitis and Secondary Bacterial Infections of Acute Bronchitis caused by Streptococcus
pneumoniae, Haemophilus
influenzae
(beta-lactamase negative strains), or Haemophilus
parainfluenzae (betalactamase negative strains) (see DOSAGE AND ADMINISTRATION and CLINICAL STUDIES).
-
5.
Uncomplicated Skin and Skin-Structure
Infections caused by Staphylococcus
aureus (including beta-lactamase?producing strains) or Streptococcus
pyogenes
.
-
6.
Uncomplicated Urinary Tract Infections caused by Escherichia coli or Klebsiella
pneumoniae.
-
7.
Uncomplicated Gonorrhea, urethral and endocervical, caused by penicillinase-producing and non-penicillinase?producing strains of Neisseria
gonorrhoeae and uncomplicated gonorrhea, rectal, in females, caused by non-penicillinase?producing strains of Neisseria
gonorrhoeae.
-
8.
Early Lyme
Disease
(
erythema
migrans
) caused by Borrelia
burgdorferi
.
CEFTIN for Oral Suspension
CEFTIN for Oral Suspension is indicated for the treatment of pediatric patients 3 months to 12 years of age with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. The safety and effectiveness of CEFTIN for Oral Suspension in the treatment of infections other than those specifically listed below have not been established either by adequate and wellcontrolled trials or by pharmacokinetic data with which to determine an effective and safe dosing regimen.
-
1.
Pharyngitis
/Tonsillitis caused by Streptococcus
pyogenes
.
-
NOTE: The usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever, is penicillin given by the intramuscular route. CEFTIN for Oral Suspension is generally effective in the eradication of streptococci from the nasopharynx; however, substantial data establishing the efficacy of cefuroxime in the subsequent prevention of rheumatic fever are not available. Please also note that in all clinical trials, all isolates had to be sensitive to both penicillin and cefuroxime. There are no data from adequate and well-controlled trials to demonstrate the effectiveness of cefuroxime in the treatment of penicillin-resistant strains of Streptococcus
pyogenes
.
-
2.
Acute Bacterial
Otitis
Media caused by Streptococcus
pneumoniae, Haemophilus
influenzae
(including beta-lactamase?producing strains), Moraxella
catarrhalis (including beta-lactamase?producing strains), or Streptococcus
pyogenes
.
-
3.
Impetigo caused by Staphylococcus
aureus (including beta-lactamase?producing strains) or Streptococcus
pyogenes.
To reduce the development of drug-resistant bacteria and maintain the effectiveness of CEFTIN and other antibacterial drugs, CEFTIN should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.
|
|
NEWS HIGHLIGHTS
Published Studies Related to Ceftin (Cefuroxime)
Neither moxifloxacin nor cefuroxime produces significant attenuation of inflammatory mediator release in patients exposed to cardiopulmonary bypass: a randomized controlled trial. [2011.10.03] OBJECTIVES: (i) the inflammatory response to CPB may be different from that of infectious disease states that were used to establish the immunomodulatory effects of moxifloxacin; and (ii) a single intravenous dose, which was used in this investigation, may not lead to high enough plasma and intracellular concentrations..
Comparative bioavailability study of cefuroxime axetil (equivalent to 500 mg cefuroxime/tablet) tablets (Zednad(R) versus Zinnat(R)) in healthy male volunteers. [2011.09] This study was performed to investigate the bioequivalence of cefuroxime axetil tablets between a generic test product (A) Zednad(R) Tablet (500 mg cefuroxime/ tablet, Diamond Pharma, Syria), and the Reference Product (B) Zinnat(R) Tablet (500 mg cefuroxime/tablet, GlaxoSmithKline, Saudi Arabia).Therefore, the two formulations were considered to be bioequivalent.
Cefuroxime as a prophylactic preoperative antibiotic in septoplasty. A double blind randomized placebo controlled study. [2011.03] BACKGROUND: Prophylactic antibiotics are often used in septoplasty. However, the number of controlled studies, especially randomized double blind placebo controlled studies on the effect of antibiotics in septum surgery, is very low. The PURPOSE OF THE PRESENT STUDY was to investigate if intravenous cefuroxime given as preoperative antimicrobial prophylaxis 30 minutes prior to surgery diminishes the risk of infection after septoplasty during the first postoperative month among patients with normal immune function... CONCLUSIONS: We recommend the use of one dose of 1500 mg intravenous cefuroxime prior to septoplasty in patients having crusts or purulent secretion in the nasal cavities or if the operation is expected to be prolonged.
Ampicillin/sulbactam versus cefuroxime as antimicrobial prophylaxis for cesarean delivery: a randomized study. [2010.11.30] BACKGROUND: The efficacy and safety of a single dose of ampicillin/sulbactam compared to a single dose of cefuroxime at cord clamp for prevention of post-cesarean infectious morbidity has not been assessed... CONCLUSIONS: Ampicillin/sulbactam was as safe and effective as cefuroxime when administered for the prevention of infections following cesarean delivery. TRIAL REGISTRATION: Clinicaltrials.gov identifier: NCT01138852.
Liquid chromatography/electrospray tandem mass spectrometry method for the determination of cefuroxime in human plasma: application to a pharmacokinetic study. [2010.02.01] A rapid, selective and sensitive high performance liquid chromatography-tandem mass spectrometry method (LC-MS/MS) was developed and validated for the determination and pharmacokinetic investigation of cefuroxime in human plasma. Cefuroxime and the internal standard (IS), cefoxitin, were extracted from plasma samples using solid phase extraction with Oasis HLB cartridges...
Clinical Trials Related to Ceftin (Cefuroxime)
Ampicillin/Sulbactam Versus Cefuroxime as Antimicrobial Prophylaxis for Cesarean Section [Completed]
The efficacy and safety of a single dose of ampicillin/sulbactam compared to a single dose
of cefuroxime at cord clamp for prevention of postcesarean infectious morbidity has not been
assessed.
Women scheduled for cesarean delivery were randomized to receive a single dose of either 3g
of ampicillin-sulbactam or 1. 5g of cefuroxime intravenously, after umbilical cord clamping.
An evaluation for development of postoperative infections and risk factor analysis was
performed.
Pharmacokinetics of Small Spectrum Beta-lactam Antibiotics (Amoxicillin/Clavulanic Acid and Cefuroxime) in Patients on Intensive Care Units [Recruiting]
Adequate antibiotic therapy is very important in the treatment of infections. Spectrum and
dosing of the antibiotics are two factors of the therapy: the spectrum of an antibiotic
can't be changed, but the dosing scheme can be optimized. Recent studies proved that an
optimized dosing scheme can improve the efficacy of the treatment. Broad-spectrum
antibiotics have unpredictable pharmacokinetics in patients on intensive care units. This is
due to the pathophysiologic processes in the patients on intensive care units: increased
distribution volume, hypoproteinemia, organ failure… The investigators guess that similar
processes influence the pharmacokinetics of small spectrum antibiotics (like amoxicillin and
cefuroxime), but data lacks. Because the pharmacokinetics of broad spectrum antibiotics in
seriously ill patients are better known, physicians are more confident prescribing these
drugs. Studying the pharmacokinetic interactions of small spectrum antibiotics in seriously
ill patients, can help to give the physician the confidence to prescribe these
small-spectrum antibiotics.
In this study, the investigators will study the pharmacokinetics of amoxicillin/clavulanic
acid and cefuroxime, in 60 patients on intensive care. 8 blood samples will be drawn via a
central catheter on different moments after one administration of the antibiotic in the
steady state phase. All the patients are prescribed the antibiotics for the treatment of
their infections: they get the antibiotic therapy anyway. By measuring the concentrations on
different moments after one administration, the investigators can reconstruct the
pharmacokinetic function.
Comparison of Doxycycline and Cefuroxime Axetil for Treatment of Erythema Migrans: Clinical and Microbiological Outcome [Completed]
Background:
- While doxycycline is a standard antibiotic for treatment of erythema migrans in Europe
as well as in the USA, the effectiveness of cefuroxime axetil in the treatment of adult
patients with erythema migrans has been assessed only in the USA where the causative
agent of Lyme disease is Borrelia burgdorferi, but not in Europe where the main
etiologic agents are B. afzelii and B. garinii.
- Controversy exists over the significance and even the existence of post-Lyme disease
symptoms because of the high rate of similar background symptoms in the general
population.
Purpose:
The two main purposes of this European, prospective clinical trial in which doxycycline and
cefuroxime axetil are compared in the treatment of adult patients with erythema migrans and
which included a control group to address the significance of post-Lyme disease symptoms
are:
- To assess and compare the effectiveness of doxycycline and cefuroxime axetil in the
treatment of erythema migrans using clinical and bacteriological criteria
(noninferiority testing approach), and
- to compare the frequency of post-Lyme disease symptoms in adult patients treated for EM
with antibiotics and the frequency of similar symptoms in control subjects without Lyme
disease.
Study of the Efficacy of Preoperative Cefuroxime Prophylaxis to Prevent Surgical Site Infection in Herniated Disk Surgery [Completed]
The purpose of the study is to determine whether a single, pre-operative dose of cefuroxime
is effective in preventing surgical site infection in patients undergoing surgery for
herniated disk
The Effect of Intracameral Cefuroxime on Post-op Fibrin in Pediatric Cataract Surgery [Completed]
The study investigates whether placing an antibiotic inside the eye at the end of cataract
surgery in children will reduce the amount of fibrin formation (fibrin formation can block
the pupil and reduce vision). We hypothesize that the fibrin is caused by a low-level
infection and could be prevented by the antibiotic.
Reports of Suspected Ceftin (Cefuroxime) Side Effects
Drug Hypersensitivity (9),
Rash (6),
Diarrhoea (4),
Photosensitivity Reaction (3),
Haemorrhage (3),
Sinusitis (3),
Abdominal Pain (2),
Hypersensitivity (2),
Pain (2),
Hepatitis (2), more >>
|
|
Page last updated: 2011-12-09
|